Drugstore Co., Ltd. (YSB) filed its latest Securities Change Month Report with Hong Kong Trading and Settlement Limited on May 6, 2024, reporting the company's stock changes as of April 30, 2024. The report showed that the company's regulated/registered share capital remained unchanged during the month, with a total outstanding balance of $50,000, a face value of $0.000025 per share and a total number of shares of 20,000,000,000 shares. In addition, under the Share Incentive Scheme for 2019 and 2023, share options were exercised and expired this month, causing the number of share options to change, but at the end of this month the number of share options outstanding was 16,920,607 shares and 13,200 new shares were issued as a result of the exercise of share options. The...Show More

Drugstore Co., Ltd. (YSB) filed its latest Securities Change Month Report with Hong Kong Trading and Settlement Limited on May 6, 2024, reporting the company's stock changes as of April 30, 2024. The report showed that the company's regulated/registered share capital remained unchanged during the month, with a total outstanding balance of $50,000, a face value of $0.000025 per share and a total number of shares of 20,000,000,000 shares. In addition, under the Share Incentive Scheme for 2019 and 2023, share options were exercised and expired this month, causing the number of share options to change, but at the end of this month the number of share options outstanding was 16,920,607 shares and 13,200 new shares were issued as a result of the exercise of share options. The 2023 Share Incentive Plan was adopted on June 12, 2023 and became effective on June 28 of the same year. The plan's authorization limit is 63,235,005 shares, which represents a maximum of 10% of the shares issued on the date of listing. The total amount of capital received from the exercise of options during the month was HK$27,044.56.